Nancy C. Andrews - 12 May 2026 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Reporting relationship: Director
Issuer ticker: CRL
Reported as of: 12 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2026, 17:11:40 UTC
Prior SEC filing: 11 May 2026
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Nancy C. Andrews

Key filing fact

Nancy C. Andrews filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 14 May 2026.

Key facts

This page summarizes Nancy C. Andrews's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 May 2026, 17:11.

Change

Previous filing in this sequence was filed on 11 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001804999 Primary reporting owner

Andrews Nancy C

Relationship: Director
Address: C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON
Signature: /s/ Nancy C. Andrews
Signature date: 14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Gift

Transaction value
Shares: -3,964
Change %: -73%
Price: $0.000000^*
Shares after: 1,438
Date: 12 May 2026
Ownership: Direct
Footnotes: F1

CRL transaction

Common Stock

Gift

Transaction value
Shares: +3,964
Change %
Price: $0.000000^*
Shares after: 3,964
Date: 12 May 2026
Ownership: By Trust
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person.